name:-0.044703006744385
name:-0.08290696144104
name:-0.0015799999237061
OSI PHARMACEUTICALS ,INC. Patent Filings

OSI PHARMACEUTICALS ,INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for OSI PHARMACEUTICALS ,INC..The latest application filed is for "process for substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines".

Company Profile
0.70.35
  • OSI PHARMACEUTICALS ,INC. -
  • OSI Pharmaceuticals, Inc. - Ardsley NY
  • OSI Pharmaceuticals, Inc. - Melville NY
  • OSI Pharmaceuticals, Inc. - Uniondale NY
  • OSI Pharmaceuticals. Inc. - 58 South Service Road Suite 110 Melville NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Process For Substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines
App 20120108812 - Dong; Hanqing ;   et al.
2012-05-03
7-aminofuropyridine Derivatives
App 20120046267 - Hornberger; Keith R. ;   et al.
2012-02-23
FUSED BICYCLIC mTOR INHIBITORS
App 20110190496 - Chen; Xin ;   et al.
2011-08-04
In situ methods for monitoring the EMT status of tumor cells in vivo
App 20110171124 - Bugaj; Joseph E. ;   et al.
2011-07-14
Amino Pyrimidine Anticancer Compounds
App 20110136764 - APPARI; Rama Devi ;   et al.
2011-06-09
Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
Grant 7,951,549 - Haley , et al. May 31, 2
2011-05-31
Fused bicyclic mTOR inhibitors
Grant 7,943,767 - Chen , et al. May 17, 2
2011-05-17
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
Grant 7,939,272 - Buck May 10, 2
2011-05-10
Fused bicyclic mTor inhibitors
Grant 7,923,555 - Chen , et al. April 12, 2
2011-04-12
Methods for the identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease
Grant 7,879,566 - Griffin , et al. February 1, 2
2011-02-01
mTOR INHIBITOR SALT FORMS
App 20110015197 - Castelhano; Arlindo L. ;   et al.
2011-01-20
Adrenocortical Carcinoma Treatment
App 20100286155 - BUCK; Elizabeth A. ;   et al.
2010-11-11
(Arylamidoaryl)squaramide compounds
Grant 7,829,717 - Castelhano , et al. November 9, 2
2010-11-09
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
Grant 7,820,662 - Arnold , et al. October 26, 2
2010-10-26
Secondary binding site of dipeptidyl peptidase IV (DP IV)
Grant 7,816,325 - Kuhn-Wache , et al. October 19, 2
2010-10-19
Isothiazole derivatives useful as anticancer agents
Grant 7,790,902 - Larson , et al. September 7, 2
2010-09-07
Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
App 20100223680 - Kan; Julie ;   et al.
2010-09-02
N-substituted imidazopyridine c-Kit inhibitors
Grant 7,767,673 - Castelhano , et al. August 3, 2
2010-08-03
Combined Treatment With An Egfr Kinase Inhibitor And An Agent That Sensitizes Tumor Cells To The Effects Of Egfr Kinase Inhibitors
App 20100166776 - Buck; Elizabeth A. ;   et al.
2010-07-01
Imidazotriazines as protein kinase inhibitors
Grant 7,741,324 - Crew , et al. June 22, 2
2010-06-22
FUSED BICYCLIC mTOR INHIBITORS
App 20100099679 - Chen; Xin ;   et al.
2010-04-22
Fused bicyclic mTOR inhibitors
Grant 7,700,594 - Chen , et al. April 20, 2
2010-04-20
(2-carboxamido)(3-Amino) thiophene compounds
Grant 7,696,225 - Bloxham , et al. April 13, 2
2010-04-13
Naphthylene derivatives as cytochrome P450 inhibitors
Grant 7,662,844 - Smith , et al. February 16, 2
2010-02-16
Unsaturated mTOR inhibitors
Grant 7,659,274 - Crew , et al. February 9, 2
2010-02-09
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
Grant 7,651,687 - Buck , et al. January 26, 2
2010-01-26
Bicyclic protein kinase inhibitors
Grant 7,648,987 - Crew , et al. January 19, 2
2010-01-19
Pyrrolopyrimidine A.sub.2B selective antagonist compounds, their synthesis and use
Grant 7,645,754 - Castelhano , et al. January 12, 2
2010-01-12
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
App 20090325928 - Arnold; Lee D. ;   et al.
2009-12-31
Alkynl and azido-substituted 4-anilinoquinazolines
Grant RE41,065 - Schnur , et al. December 29, 2
2009-12-29
Substituted Imidazopyr- And Imidazotri-azines
App 20090286768 - Crew; Andrew P. ;   et al.
2009-11-19
(Arylamidoanilino)nitroethylene compounds
Grant 7,618,965 - Crew , et al. November 17, 2
2009-11-17
Peptidyl ketones as inhibitors of DPIV
Grant 7,608,577 - Heiser , et al. October 27, 2
2009-10-27
Compounds specific to adenosine A, receptors and uses thereof
Grant 7,598,252 - Castelhano , et al. October 6, 2
2009-10-06
Furo- and Thieno [3,2-c] Pyridines
App 20090197864 - Li; An-Hu ;   et al.
2009-08-06
2-aminopyridine Kinase Inhibitors
App 20090197862 - Steinig; Arno G. ;   et al.
2009-08-06
2-ARYL pyrrologpyrimidines for A1 and A3 receptors
App 20090192177 - Castelhano; Arlindo L. ;   et al.
2009-07-30
Substituted thienol[2,3-d]pyrimidines as kinase inhibitors
Grant 7,566,721 - Ji , et al. July 28, 2
2009-07-28
Imidazopyrazine Tyrosine Kinase Inhibitors
App 20090181940 - Beck; Patricia Anne ;   et al.
2009-07-16
Fused Bicyclic mTor Inhibitors
App 20090163468 - Chen; Xin ;   et al.
2009-06-25
6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors
Grant 7,534,797 - Arnold , et al. May 19, 2
2009-05-19
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
App 20090118499 - Arnold; Lee D. ;   et al.
2009-05-07
(2-carboxamido)(3-amino)thiophene compounds
Grant 7,524,859 - Crew April 28, 2
2009-04-28
Methods for identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease
Grant 7,524,638 - Griffin , et al. April 28, 2
2009-04-28
N-substituted benzimidazolyl c-Kit inhibitors
Grant 7,521,448 - Bolger , et al. April 21, 2
2009-04-21
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
Grant 7,521,456 - Allen , et al. April 21, 2
2009-04-21
Pyrrolo[2,3d]pyrimidine compositions and their use
App 20090082369 - Castelhano; Arlindo L. ;   et al.
2009-03-26
Compounds specific to adenosine A.sub.1 and A.sub.3 receptors and uses thereof
Grant 7,504,407 - Castelhano , et al. March 17, 2
2009-03-17
Pyrimidine A.sub.2B selective antagonist compounds, their synthesis and use
Grant 7,501,407 - Castelhano , et al. March 10, 2
2009-03-10
N-Substituted Imidazopyridine c-Kit Inhibitors
App 20090062275 - Castelhano; Arlindo L. ;   et al.
2009-03-05
Pyrrolo[2,3-D]imidazoles for the treatment of hyperproliferative disorders
Grant 7,498,354 - Crew , et al. March 3, 2
2009-03-03
N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors
Grant 7,485,658 - Bolger , et al. February 3, 2
2009-02-03
Substituted pyrrolo[2.3-B]pyridines
Grant 7,465,726 - Ahmed , et al. December 16, 2
2008-12-16
Imidazopyrazine tyrosine kinase inhibitors
Grant 7,459,554 - Dong , et al. December 2, 2
2008-12-02
N3-substituted imidazopyridine c-Kit inhibitors
Grant 7,442,709 - Castelhano , et al. October 28, 2
2008-10-28
Pyrrolopyrimidine A2b Selective Antagonist Compounds, Their Synthesis And Use
App 20080261943 - Castelhano; Arlindo ;   et al.
2008-10-23
4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use
Grant 7,429,574 - Castelhano , et al. September 30, 2
2008-09-30
N-substituted benzimidazoyl c-Kit inhibitors and combinatorial benzimidazole library
Grant 7,419,995 - Crew , et al. September 2, 2
2008-09-02
Isothiazole derivatives useful as anticancer agents
Grant 7,405,218 - Larson , et al. July 29, 2
2008-07-29
Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
Grant 7,405,210 - Bradley , et al. July 29, 2
2008-07-29
(Hydrazido)(amino)thiophene compounds
Grant 7,388,012 - Crew , et al. June 17, 2
2008-06-17
Compounds specific to adenosine A1 receptors and uses thereof
App 20080070936 - Castelhano; Arlindo L. ;   et al.
2008-03-20
Compounds specific to adenosine A.sub.3 receptor and uses thereof
Grant 7,160,890 - Castelhano , et al. January 9, 2
2007-01-09
AGS proteins and nucleic acid molecules and uses therefor
Grant 7,144,711 - Cismowski , et al. December 5, 2
2006-12-05
Method of inhibiting neoplastic cells with indole derivatives
Grant 7,115,647 - Pamukcu , et al. October 3, 2
2006-10-03
(2-Carboxamido)(3-amino)thiophene compounds
Grant 7,101,893 - Crew September 5, 2
2006-09-05
Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
Grant 7,087,613 - Norris , et al. August 8, 2
2006-08-08
Pancreatic lipase inhibitor compounds, their synthesis and use
Grant 7,064,122 - Witter , et al. June 20, 2
2006-06-20
Pyrimidine A2b selective antagonist compounds, their synthesis and use
Grant 6,916,804 - Castelhano , et al. July 12, 2
2005-07-12
Pyrimidine A2B selective antagonist compounds, their synthesis and use
App 20050119271 - Castelhano, Arlindo ;   et al.
2005-06-02
Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
Grant 6,900,221 - Norris , et al. May 31, 2
2005-05-31
Stable polymorph of N-(3-ethynylphenyl)-6, 7-bis (2-methoxyethoxy)-4-quina- zolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
App 20050090500 - Norris, Timothy ;   et al.
2005-04-28
Compounds specific to adenosine A1 receptor and uses thereof
Grant 6,878,716 - Castelhano , et al. April 12, 2
2005-04-12
Diagnostic methods for neoplasia
Grant 6,875,575 - Pamukcu , et al. April 5, 2
2005-04-05
Method for treating a patient with neoplasia by treatment with a platinum coordination complex
Grant 6,869,944 - Pamukcu , et al. March 22, 2
2005-03-22
Pyrrolo[2,3d]pyrimidine compositions and their use
App 20050043332 - Castelhano, Arlindo L. ;   et al.
2005-02-24
Preparation of a camptothecin derivative by intramolecular cyclisation
Grant 6,821,982 - Fang , et al. November 23, 2
2004-11-23
Pyrrolo[2,3d]pyrimidine compositions and their use
Grant 6,800,633 - Castelhano , et al. October 5, 2
2004-10-05
AGS proteins and nucleic acid molecules and uses therefor
App 20040180375 - Cismowski, Mary ;   et al.
2004-09-16
Species specific DNA detection
App 20040146881 - Allen-Hoffmann, Lynn ;   et al.
2004-07-29
AGS proteins and nucleic acid molecules and uses thereof
Grant 6,746,852 - Cismowski , et al. June 8, 2
2004-06-08
N- (3-ethynylphenyl) -6, 7-bis (2-methoxyethoxy) -4-quinazolinamine mesylate anhydrate and monohydrate
App 20040102463 - Allen, Douglas John Meldrum ;   et al.
2004-05-27
Liposomal camptothecin formulations
Grant 6,740,335 - Moynihan , et al. May 25, 2
2004-05-25
AGS proteins and nucleic acid molecules and uses therefor
Grant 6,733,991 - Cismowski , et al. May 11, 2
2004-05-11
Compounds specific to adenosine A1 receptors and uses thereof
App 20040082599 - Castelhano, Arlindo L. ;   et al.
2004-04-29
Compounds specific to adenosine A, receptors and uses thereof
App 20040082598 - Castelhano, Arlindo L. ;   et al.
2004-04-29
Method for preparing camptothecin derivatives
Grant 6,716,982 - Fang , et al. April 6, 2
2004-04-06
Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
App 20040057990 - Ashvar, Claudine S. ;   et al.
2004-03-25
N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
Grant 6,706,721 - Allen , et al. March 16, 2
2004-03-16
Methods for treatment of inflammatory bowel disease
Grant 6,699,894 - Earle , et al. March 2, 2
2004-03-02
Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
Grant 6,689,381 - Ashvar , et al. February 10, 2
2004-02-10
Compounds specific to adenosine A3 receptor and uses thereof
Grant 6,686,366 - Castelhano , et al. February 3, 2
2004-02-03
Compounds specific to adenosine A1 receptors and uses thereof
Grant 6,680,322 - Castelhano , et al. January 20, 2
2004-01-20
Compounds specific to adenosine A1 receptors and uses thereof
Grant 6,680,324 - Castelhano , et al. January 20, 2
2004-01-20
Compounds specific to adenosine A3 receptor and uses thereof
Grant 6,673,802 - Castelhano , et al. January 6, 2
2004-01-06
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
Grant 6,664,252 - Castelhano , et al. December 16, 2
2003-12-16
Preparation of a camptothecin derivative by intramolecular cyclisation
App 20030204088 - Fang, Francis Gerard ;   et al.
2003-10-30
Conformationallly constrained peptidomimetics as .beta.-turn templates and modulators of SH3 domains
Grant 6,638,941 - Castelhano , et al. October 28, 2
2003-10-28
Methods of discovering chemicals capable of functioning as gene expression modulators
App 20030166281 - Foulkes, J. Gordon ;   et al.
2003-09-04
Bicyclic pyrimidinyl derivatives and methods of use thereof
App 20030139427 - Castelhano, Arlindo L. ;   et al.
2003-07-24
Preparation of a camptothecin derivative by intramolecular cyclisation
App 20030045719 - Fang, Francis Gerard ;   et al.
2003-03-06
Methods of discovering chemicals capable of functioning as gene expression modulators
Grant 6,376,175 - Foulkes , et al. April 23, 2
2002-04-23
Methods of transcriptionally modulating expression of viral genes and genes useful for production of proteins
Grant 6,165,712 - Foulkes , et al. December 26, 2
2000-12-26
Methods of specifically transcriptionally modulating the expression of gene of interest
Grant 6,136,779 - Foulkes , et al. October 24, 2
2000-10-24
Tetracyclic compounds for enhancing biosynthesis of erythropoietin, compositions containing same, and methods of use thereof
Grant 5,985,913 - Williams , et al. November 16, 1
1999-11-16
Company Registrations
CAGE Code35QZ8OSI PHARMACEUTICALS INC OSI PHARMACEUTICALS, INC
SEC0000729922OSI PHARMACEUTICALS INC of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed